Company / Revenue per Share
ENDRA Life Sciences Inc. Revenue per Share History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
-
FY2020
5-year range
$0.00 / $0.49
FY2017-FY2020
Trend
-100.0%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.09 to $0.00 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- ENDRA Life Sciences Inc.'s revenue per share has declined for 3 consecutive years.
- In FY2020, revenue per share decreased 100.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -7.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $0.00 | -100.0% |
| FY2019 | $0.00 | -99.1% |
| FY2018 | $0.09 | -81.6% |
| FY2017 | $0.49 | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026